Filing Details
- Accession Number:
- 0001104659-21-144901
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-30 14:49:21
- Reporting Period:
- 2021-11-29
- Accepted Time:
- 2021-11-30 14:49:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1815903 | Petros Pharmaceuticals Inc. | PTPI | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1208886 | D John Shulman | 1185 Avenue Of The Americas, 3Rd Floor New York NY 10036 | Yes | No | Yes | No | |
1835386 | Jcp Iii Sm Aiv, L.p. | 1185 Avenue Of The Americas, 3Rd Floor New York NY 10036 | No | No | Yes | No | |
1835421 | Juggernaut Partners Iii Gp, L.p. | 1185 Avenue Of The Americas, 3Rd Floor New York NY 10036 | No | No | Yes | No | |
1835433 | Juggernaut Partners Iii Gp, Ltd. | 1185 Avenue Of The Americas, 3Rd Floor New York NY 10036 | No | No | Yes | No | |
1836319 | Metp Holdings Llc | 1185 Avenue Of The Americas, 3Rd Floor New York NY 10036 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2021-11-29 | 500,000 | $3.00 | 5,557,771 | No | 4 | P | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See Footnote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrant | Acquisiton | 2021-11-29 | 375,000 | $0.00 | 375,000 | $3.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
375,000 | 2021-12-02 | 2026-12-02 | No | 4 | P | Indirect |
Footnotes
- See Note (1) in Exhibit 99.1.